Use of Anthracyclines Should Be Re-Evaluated for Treatment of Breast Cancer

According to Sara Hurvitz, medical oncologist, and professor of medicine at the University of Washington, Fred Hutchinson Cancer Center the severe side effects of anthracyclines
are underestimated in the treatment of breast cancer. In this MEDtalk, Sarah Hurvitz argues why the use of anthracyclines should be re-evaluated.